HumanFirst accelerates patient-centered research and drives R&D efficiency through the most comprehensive AI-powered insights and evidence platform for precision measures – helping biopharma measure what matters to bring differentiated treatments to market, faster. Previously known as Elektra Labs, HumanFirst's SaaS solutions have been used by 22 of the 25 largest pharmaceutical companies in the world to evaluate and enable precision measures in clinical research. HumanFirst has raised a Series A round of funding led by Maverick Ventures, participation from Lux Capital, Threshold Ventures, Arkitekt Ventures, Boost VC, SV Angel, Village Global, and more than 30 angel investors. This investment brings HumanFirst’s total funding to $15M since the company’s inception.